These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 9815709

  • 1. Decreased antigen presentation by dendritic cells in patients with breast cancer.
    Gabrilovich DI, Corak J, Ciernik IF, Kavanaugh D, Carbone DP.
    Clin Cancer Res; 1997 Mar; 3(3):483-90. PubMed ID: 9815709
    [Abstract] [Full Text] [Related]

  • 2. Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency.
    Gervais A, Levêque J, Bouet-Toussaint F, Burtin F, Lesimple T, Sulpice L, Patard JJ, Genetet N, Catros-Quemener V.
    Breast Cancer Res; 2005 Mar; 7(3):R326-35. PubMed ID: 15987427
    [Abstract] [Full Text] [Related]

  • 3. Dendritic cells fused with allogeneic breast cancer cell line induce tumor antigen-specific CTL responses against autologous breast cancer cells.
    Zhang Y, Ma B, Zhou Y, Zhang M, Qiu X, Sui Y, Zhang X, Ma B, Fan Q.
    Breast Cancer Res Treat; 2007 Nov; 105(3):277-86. PubMed ID: 17187233
    [Abstract] [Full Text] [Related]

  • 4. Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.
    Avigan D, Wu Z, Gong J, Joyce R, Levine J, Elias A, Richardson P, Milano J, Kennedy L, Anderson K, Kufe D.
    Clin Cancer Res; 1999 Oct; 5(10):2735-41. PubMed ID: 10537336
    [Abstract] [Full Text] [Related]

  • 5. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
    Palucka AK, Ueno H, Connolly J, Kerneis-Norvell F, Blanck JP, Johnston DA, Fay J, Banchereau J.
    J Immunother; 2006 Oct; 29(5):545-57. PubMed ID: 16971810
    [Abstract] [Full Text] [Related]

  • 6. Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor.
    Shilyansky J, Jacobs P, Doffek K, Sugg SL.
    J Pediatr Surg; 2007 Jan; 42(1):54-61; discussion 61. PubMed ID: 17208541
    [Abstract] [Full Text] [Related]

  • 7. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
    Delirezh N, Moazzeni SM, Shokri F, Shokrgozar MA, Atri M, Kokhaei P.
    Cell Immunol; 2009 Jan; 257(1-2):23-31. PubMed ID: 19306994
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum-free culture of dendritic cells from patients with chronic myeloid leukemia in vitro and estimation of their cytotoxicity.
    Zhao W, Xing P, Wei X, Wang T, Yang D, Li M.
    Chin Med J (Engl); 2002 Sep; 115(9):1296-300. PubMed ID: 12411098
    [Abstract] [Full Text] [Related]

  • 10. Ovarian carcinoma cells influence differentiation of Lin-CD45RA- dendritic cell precursors into two mature subtypes in vitro.
    Chen LL, Ye F, Yu Y, Chen HZ, Zhang WW, Lü WG, Xie X.
    Gynecol Oncol; 2009 Jan; 112(1):199-204. PubMed ID: 19022493
    [Abstract] [Full Text] [Related]

  • 11. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.
    Mulders P, Tso CL, Gitlitz B, Kaboo R, Hinkel A, Frand S, Kiertscher S, Roth MD, deKernion J, Figlin R, Belldegrun A.
    Clin Cancer Res; 1999 Feb; 5(2):445-54. PubMed ID: 10037196
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL, Zisman A, Pantuck A, Calilliw R, Hernandez JM, Paik S, Nguyen D, Gitlitz B, Shintaku PI, de Kernion J, Figlin R, Belldegrun A.
    Cancer Res; 2001 Nov 01; 61(21):7925-33. PubMed ID: 11691814
    [Abstract] [Full Text] [Related]

  • 14. Novel system for generating cytotoxic effector lymphocytes using carcinoembryonic antigen (CEA) peptide and cultured dendritic cells.
    Ohta K, Yamaguchi Y, Shimizu K, Miyahara E, Toge T.
    Anticancer Res; 2002 Nov 01; 22(5):2597-606. PubMed ID: 12529970
    [Abstract] [Full Text] [Related]

  • 15. FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function.
    Chen W, Chan AS, Dawson AJ, Liang X, Blazar BR, Miller JS.
    Biol Blood Marrow Transplant; 2005 Jan 01; 11(1):23-34. PubMed ID: 15625541
    [Abstract] [Full Text] [Related]

  • 16. Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC.
    Ramadan G, Konings S, Kurup VP, Keever-Taylor CA.
    Cytotherapy; 2004 Jan 01; 6(3):223-34. PubMed ID: 15203979
    [Abstract] [Full Text] [Related]

  • 17. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
    Choi D, Perrin M, Hoffmann S, Chang AE, Ratanatharathorn V, Uberti J, McDonagh KT, Mulé JJ.
    Clin Cancer Res; 1998 Nov 01; 4(11):2709-16. PubMed ID: 9829733
    [Abstract] [Full Text] [Related]

  • 18. Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers.
    Bohnenkamp HR, Coleman J, Burchell JM, Taylor-Papadimitriou J, Noll T.
    Cell Immunol; 2004 Nov 01; 231(1-2):112-25. PubMed ID: 15919376
    [Abstract] [Full Text] [Related]

  • 19. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
    Koido S, Hara E, Homma S, Torii A, Toyama Y, Kawahara H, Watanabe M, Yanaga K, Fujise K, Tajiri H, Gong J, Toda G.
    Clin Cancer Res; 2005 Nov 01; 11(21):7891-900. PubMed ID: 16278414
    [Abstract] [Full Text] [Related]

  • 20. Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line.
    Yin XY, Wang L, Lu MD, Li BJ, Huang JF.
    Hepatogastroenterology; 2008 Nov 01; 55(81):155-9. PubMed ID: 18507097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.